Jennewein and Yili sign MoU to develop innovative infant formula
date:Feb 20, 2019
Chinese parents and their children.

HMOs constitute the third-largest component of breast milk and are unique to humans in concentration and structural diversity. HMOs possess several physiological effects; they confer protection against infectious diseases (e.g. noro viruses) and act as prebiotics for the development of the infant microbiome.

Today, it is widely recognised that the establishment of a healthy microbiome is key for the overall development of an infant. Failure to support a natu
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/19 04:51